Earth Science Tech Inc (OTCMKTS:ETST) reported the plunge of -6.25% and closed at $1.50, with the total traded volume of 12,266.00 shares. During last trade its minimum price was $1.38 and it gained its highest price of $1.61 and has a total of 40.91 million outstanding shares.
Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, sports, and alternative medicine worldwide. It focuses on non-prescription nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. The company also provides consulting services to the athletic facilities industry. Its marketing services include direct marketing, search engine optimization, public relations, email marketing, social media marketing, and development of referral programs. In addition, Earth Science Tech, Inc. retails health and wellness brands, as well as sports nutrition and dietary supplement products; and stocks and sells high grade cannabidiol rich hemp oil and products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in April 2014. The company was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Pharmacyte Biotech Inc (OTCMKTS:PMCB) showing dropped of -2.04% and closed at $0.0960, after gaining total volume of 980,747.00 shares. Its earnings per share (EPS) is -$0.01 and its beta value stands at 2.51 points and has total market capitalization of $82.76 million and a total of 875.31 million outstanding shares.
PharmaCyte Biotech, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology, known as Cell-in-a-Box. Its Cell-in-a-Box technology would be used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, and diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of the cancer. It is also developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes; and examining the benefits of the Cell-in-a-Box technology to develop therapies for cancer based upon the constituents of the Cannabis plant. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was founded in 1996 and is based in Silver Spring, Maryland.
POTNETWORK HLDGS I COM USD0.0001(POST REV SPLI (OTCMKTS:POTN) decreased -6.02% closed at $0.0390 and traded with total volume of 2.88M shares, while the average trading remained 4.11M shares. During last trade its minimum price was $0.04 and it gained the highest price of $0.05. Its market capitalization was $2.89 million.
POTNETWORK HLDGS I COM USD0.0001(POST REV SPLI (POTN) on March 28, 2017 announced today that upon starting 2017 with the advantageous acquisition of Diamond CBD, Inc. and the Company’s transition back into the cannabis, hemp and related markets, coupled with Diamond CBD’s robust sales pipeline, the Company is projected to generate over $1,700,000.00 in gross revenues during the first quarter of 2017 alone.
Regarding developments, Maria Gomez, Regional Vice President of Sales, Diamond CBD, stated: “As the marijuana sector continues to expand, so has our corporate vision and drive for brand distinction and differentiation. For Diamond CBD, sales have accelerated from $1,663,081.78 for the 4 quarters of 2016 to a pace that will probably exceed $1,700,000.00 for the 1st quarter of 2017, meaning that we’ve established significant momentum for the remainder of this year. Even if sales only remain consistent, it would represent a revenue increase in the range of almost 400% percent, year-over-year.”
In accordance with the Company’s aggressive branding and marketing strategy, its subsidiary, Diamond CBD, Inc., exhibited at ASD Market Week, in Las Vegas, NV, an international event known to showcase the world’s widest variety of popular retail merchandise in a one-stop shopping experience. ASD Market Week boasts 45,000 buyers from 88 countries annually. Ninety-eight percent of these attendees have major purchasing power with the average buyer spending $82,500.00 per show, equating to $2.8 billion annually.